Eradication of Helicobacter pylori: current perspectives

Area of Science:

• Gastroenterology
• Infectious Diseases
• Microbiology

Background:

• Helicobacter pylori (H. pylori) is a primary cause of duodenal and gastric ulcers.
• H. pylori infection is a persistent and transmissible disease that is difficult to eradicate.
• Over 1000 clinical trials have investigated H. pylori eradication regimens in the past decade.

Purpose of the Study:

• To review past, present, and future H. pylori eradication regimens.
• To discuss limitations of previous clinical trials.
• To highlight challenges in H. pylori management, including eradication failures and drug resistance.

Main Methods:

• Review of >1000 clinical trials on H. pylori eradication.
• Analysis of historical, current, and potential future treatment strategies.
• Discussion of factors contributing to eradication failures and antimicrobial resistance.

Main Results:

• H. pylori is a necessary factor in most non-drug-related duodenal and gastric ulcers.
• Numerous eradication regimens have been trialed, but many studies had significant limitations.
• Eradication failures and increasing drug resistance complicate H. pylori management.

Conclusions:

• Effective H. pylori eradication is essential for treating peptic ulcer disease.
• Ongoing research and critical evaluation of clinical trials are needed to improve treatment outcomes.
• Addressing eradication failures and antimicrobial resistance is crucial for future therapeutic strategies.